BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23194425)

  • 1. Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.
    Pichler V; Heffeter P; Valiahdi SM; Kowol CR; Egger A; Berger W; Jakupec MA; Galanski MS; Keppler BK
    J Med Chem; 2012 Dec; 55(24):11052-61. PubMed ID: 23194425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
    Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
    Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
    Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
    Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.
    Varbanov HP; Göschl S; Heffeter P; Theiner S; Roller A; Jensen F; Jakupec MA; Berger W; Galanski MS; Keppler BK
    J Med Chem; 2014 Aug; 57(15):6751-64. PubMed ID: 25032896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
    Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
    Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.
    Scaffidi-Domianello YY; Legin AA; Jakupec MA; Roller A; Kukushkin VY; Galanski MS; Keppler BK
    Inorg Chem; 2012 Jul; 51(13):7153-63. PubMed ID: 22691006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of complexes based on p-nitrobenzoylhydrazide, benzoylformic acid and diorganotin halides or oxides self-assemble: Cytotoxicity, the induction of apoptosis in cancer cells and DNA-binding properties.
    Jiang W; Fan S; Zhou Q; Zhang F; Kuang D; Tan Y
    Bioorg Chem; 2020 Jan; 94():103402. PubMed ID: 31718891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines.
    Ginzinger W; Mühlgassner G; Arion VB; Jakupec MA; Roller A; Galanski MS; Reithofer M; Berger W; Keppler BK
    J Med Chem; 2012 Apr; 55(7):3398-413. PubMed ID: 22417128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cis- and trans-configured bis(oxime)platinum(II) complexes: synthesis, characterization, and cytotoxic activity.
    Scaffidi-Domianello YY; Meelich K; Jakupec MA; Arion VB; Kukushkin VY; Galanski MS; Keppler BK
    Inorg Chem; 2010 Jun; 49(12):5669-78. PubMed ID: 20459062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
    Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
    Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
    Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
    J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
    Huang X; Wang M; Wang C; Hu W; You Q; Yang Y; Yu C; Liao Z; Gou S; Wang H
    Bioorg Chem; 2019 Nov; 92():103236. PubMed ID: 31494328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
    Ma L; Ma R; Wang Z; Yiu SM; Zhu G
    Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
    Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
    Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction.
    Wang H; Wei J; Jiang H; Zhang Y; Jiang C; Ma X
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracarboxylatoplatinum(IV) complexes featuring monodentate leaving groups - A rational approach toward exploiting the platinum(IV) prodrug strategy.
    Höfer D; Varbanov HP; Legin A; Jakupec MA; Roller A; Galanski MS; Keppler BK
    J Inorg Biochem; 2015 Dec; 153():259-271. PubMed ID: 26365319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.